Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-05-12

FDA Approved: FULVESTRANT — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Fulvestrant from Fresenius Kabi USA, LLC. The submission appears to concern a labeling-related update for the produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

SUPPL AP for FULVESTRANT (FULVESTRANT)